Aprea Therapeutics Statistics
NASDAQ: APREHealthcareBiotechnologyUSD
0.5582-0.0468 (-7.74%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Aprea Therapeutics by the numbers
Aprea Therapeutics has a market capitalization of $7.0 million based on 12.59M shares outstanding. With trailing EPS of $-0.95, Aprea Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.4% below its 50-day average and 28.6% below its 200-day average.
Average daily trading volume is 280.14K shares, or about $156,374 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
APRE valuation vs. peer median
| Metric | APRE | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.03M | $6.99M | +1% |
| Avg. volume | 280.14K | 96.06K | +192% |
Peer median across 8 companies: BOLT, ACXP, AIM, ENVB, NRSN, LEXX, TRAW, SKYE.
Valuation
- Market cap
- $7.03M
- EPS (TTM)
- $-0.95
- Shares outstanding
- 12.59M
Price and trading
- Previous close
- 0.605
- Open
- 0.608
- Day range
- 0.55 – 0.608
- 52-week range
- 0.548 – 1.69
- 50-day moving average
- 0.7283
- 200-day moving average
- 0.7823
- Beta
- —
- Volume
- 235.47K
- Average volume
- 280.14K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 7.03M
- Forward Pe
- -1.64
- Eps
- -0.95
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.69
- Week52 Low
- 0.55
- Avg Volume
- 280.14K
- Shares Outstanding
- 12.59M
- Ma50
- 0.73
- Ma200
- 0.78
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -66.97%
- Pct From52w Low
- 1.86%